ClinicalTrials.gg

Program

KH001

A development code. Also written as “KH-001 besylate” and “KH-001 ODT”.

Its studies are mostly in Dentin Sensitivity · Premature Ejaculation, led by 2 companies.

Furthest: phase 2, since Mar 9, 20215 company-led studies, 1 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
HysensBio30 open or runningphase 2since Mar 9, 2021Mar 9, 2021none ahead
Kadence Bio21 open or runningphase 2since Dec 10, 2025Dec 10, 2025none ahead

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Mar 9, 2021First study: phase 2 study in Dentin SensitivityNew to HysensBioHysensBio · NCT04804514 · 40 enrolled · Korea, Republic of
  2. Feb 9, 2024Phase 2 study in Dentin SensitivityHysensBio · NCT06264453 · 171 enrolled · Korea, Republic of
  3. Jun 13, 2024Phase 2 study in Dentin SensitivityHysensBio · NCT06464939 · 120 enrolled · United States
  4. Dec 10, 2025Kadence Bio's first study: phase 2 study in Premature EjaculationNew to Kadence BioKadence Bio · NCT07434271 · 40 planned · Australia
  5. Sep 25, 2026Phase 1 study in Premature EjaculationKadence Bio · NCT07868237 · 82 enrolled · United Kingdom

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 5 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusLed byPrimary completionSize
NCT07868237Premature Ejaculation · United Kingdom1CompletedKadence BioAug 28, 202582
NCT07434271Premature Ejaculation · Australia2RecruitingKadence BioOct 31, 202640
NCT06464939Dentin Sensitivity · United States2CompletedHysensBioDec 22, 2025120
NCT06264453Dentin Sensitivity · Korea, Republic of2CompletedHysensBioSep 25, 2024171
NCT04804514Dentin Sensitivity · Korea, Republic of2CompletedHysensBioMar 3, 202340

How it is read

Names in the registry

  • “KH001”, 3 entries
  • “KH-001 besylate”, 1 entry
  • “KH-001 ODT”, 1 entry

Codes read as this program: KH001.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.